{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:31:16Z","timestamp":1786707076191,"version":"build-2736575974"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Clostridioides difficile infection (CDI) is a leading cause of healthcare-associated diarrhoea and a marker of antimicrobial exposure and healthcare quality, yet Central Asia is almost absent from the indexed literature. We reviewed available evidence on CDI epidemiology, antimicrobial use and molecular typing across Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan and Turkmenistan, searching PubMed\/MEDLINE, Google Scholar and accessible regional sources, and identified priorities for surveillance development. The retrievable evidence is sparse and fragmented. The strongest direct data came from Uzbekistan, where paediatric cohorts documented toxigenic C. difficile in up to 47% of the aetiological structure of antibiotic-associated diarrhoea in early-aged children. Nationwide surveys in Kazakhstan showed substantial antimicrobial use (38.2\u201340.2% of inpatients) and measurable healthcare-associated infection burdens (2.4\u20133.8%), indicating environments in which CDI may go unrecognised. No national CDI surveillance, ribotyping or resistance-gene data were identified for any of the five countries, whereas evidence from China, Thailand and other Asian settings indicates that ribotype 017 (sequence type 37) predominates in those countries. This absence appears more consistent with underdiagnosis, fragmented reporting and limited laboratory capacity than with true absence of disease. Sentinel surveillance, standardised diagnostic algorithms, integration with antimicrobial stewardship and infection prevention programmes, and regional typing collaborations are the practical priorities.<\/jats:p>","DOI":"10.3390\/pathogens15080853","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:39:01Z","timestamp":1786703941000},"page":"853","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clostridioides difficile Infection in Central Asia: Current Evidence, Molecular Epidemiology, and Surveillance Priorities\u2014A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8111-0256","authenticated-orcid":false,"given":"Dilshat Zamirovich","family":"Mukhamejanov","sequence":"first","affiliation":[{"name":"Scientific Research Laboratory, Karaganda Medical University, 12 Orskaya Street, Karaganda 100022, Kazakhstan"},{"name":"Department of Infectious Diseases and Phthisiology, Karaganda Medical University, 12 Orskaya Street, Karaganda 100022, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-8778","authenticated-orcid":false,"given":"Alyona Vladimirovna","family":"Lavrinenko","sequence":"additional","affiliation":[{"name":"Scientific Research Laboratory, Karaganda Medical University, 12 Orskaya Street, Karaganda 100022, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-5038","authenticated-orcid":false,"given":"Abdurakhim","family":"Toychiev","sequence":"additional","affiliation":[{"name":"Republican Specialized Scientific and Practical Medical Center of Epidemiology, Microbiology, Infectious and Parasitic Diseases, 2 Zakovat Street, Tashkent 100133, Uzbekistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazliddin Khayriddin ogli","family":"Gaybullayev","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Pediatric Infectious Diseases, Tashkent State Medical University, 2 Farabi Street, Tashkent 100109, Uzbekistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1093\/cid\/cis319","article-title":"Current status of Clostridium difficile infection epidemiology","volume":"55","author":"Lessa","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"010407","DOI":"10.7189\/jogh.09.010407","article-title":"Global burden of Clostridium difficile infections: A systematic review and meta-analysis","volume":"9","author":"Balsells","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Akorful, R.A.A., Odoom, A., Awere-Duodu, A., and Donkor, E.S. (2025). Global burden of Clostridioides difficile infections, 2016\u20132024: Systematic review and meta-analysis. Infect. Dis. Rep., 17.","DOI":"10.3390\/idr17020031"},{"key":"ref_5","unstructured":"European Centre for Disease Prevention and Control (2024). Clostridioides difficile Infections: Annual Epidemiological Report for 2018\u20132020, ECDC."},{"key":"ref_6","unstructured":"European Centre for Disease Prevention and Control (2019). European surveillance of Clostridioides difficile Infections: Surveillance Protocol Version 2.4, ECDC."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by IDSA and SHEA","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1473-3099(14)70991-0","article-title":"Underdiagnosis of Clostridium difficile across Europe: The EUCLID study","volume":"14","author":"Davies","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/22221751.2019.1702480","article-title":"Clostridioides difficile infection in the Asia-Pacific region","volume":"9","author":"Collins","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102821","DOI":"10.1016\/j.anaerobe.2024.102821","article-title":"Burden of Clostridioides difficile in South-East Asia and the Western Pacific","volume":"86","author":"Angulo","year":"2024","journal-title":"Anaerobe"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2047-2994-2-21","article-title":"Epidemiology of Clostridium difficile infection in Asia","volume":"2","author":"Collins","year":"2013","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/22221751.2019.1621670","article-title":"Clostridium difficile ribotype 017\u2014characterization, evolution and epidemiology of the dominant strain in Asia","volume":"8","author":"Imwattana","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2019.10.023","article-title":"Clostridium difficile and One Health","volume":"26","author":"Lim","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/JCM.01296-16","article-title":"Comparative genome analysis and global phylogeny of the toxin variant Clostridium difficile PCR ribotype 017 reveals the evolution of two independent sublineages","volume":"55","author":"Cairns","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Li, Z., Heuler, J., Zhu, D., Meng, X., Chakraborty, S., Harmanus, C., Wang, S., Peng, Z., Smits, W.K., and Wu, A. (2024). Genomic and phenotypic characterization of a Clostridioides difficile strain of the epidemic ST37 type from China. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1412408"},{"key":"ref_16","first-page":"mgen000792","article-title":"Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017","volume":"8","author":"Imwattana","year":"2022","journal-title":"Microb. Genom."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Semenova, Y., Yessmagambetova, A., Akhmetova, Z., Smagul, M., Zharylkassynova, A., Aubakirova, B., Soiak, K., Kosherova, Z., Aimurziyeva, A., and Makalkina, L. (2024). Point-prevalence survey of antimicrobial use and healthcare-associated infections in four acute care hospitals in Kazakhstan. Antibiotics, 13.","DOI":"10.3390\/antibiotics13100981"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13756-025-01667-7","article-title":"Prevalence of healthcare-associated infections and antimicrobial use in Kazakhstan","volume":"14","author":"Smagul","year":"2025","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Semenova, Y., Yergaliyeva, A., Aimurziyeva, A., Manatova, A., Kuntuganova, A., Makalkina, L., Aldiyarova, N., Semenov, D., and Lim, L. (2024). Antibiotic consumption in Kazakhstan from 2019 to 2023. Antibiotics, 13.","DOI":"10.3390\/antibiotics13121123"},{"key":"ref_20","first-page":"18","article-title":"Clinical aspects of antibiotic-associated diarrhoea in children","volume":"1","author":"Kamilova","year":"2018","journal-title":"Pediatr. Det. Khirurgiya"},{"key":"ref_21","first-page":"12","article-title":"Role of Clostridium difficile in antibiotic-associated diarrhoea in early-aged children","volume":"4","author":"Rabbimova","year":"2024","journal-title":"Int. J. Med. Sci. Clin. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1128\/JCM.00587-13","article-title":"Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: An underrecognized problem in Asia?","volume":"51","author":"Hawkey","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/JCM.01898-16","article-title":"Molecular epidemiology of Clostridium difficile infection in hospitalized patients in eastern China","volume":"55","author":"Jin","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/22221751.2021.1943538","article-title":"Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China","volume":"10","author":"Xu","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Cui, Y., Zhang, C., Jia, Q., Gong, X., Tan, Y., Hua, X., Jian, W., Yang, S., Hayer, K., and Idris, R.K.R. (2023). An epidemiological surveillance study (2021\u20132022): Detection of a high diversity of Clostridioides difficile isolates in one tertiary hospital in Chongqing, Southwest China. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08666-2"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nmni.2017.04.006","article-title":"Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia","volume":"18","author":"Collins","year":"2017","journal-title":"New Microbes New Infect."},{"key":"ref_27","first-page":"258","article-title":"Epidemiology of Clostridium (Clostridioides) difficile infection in Southeast Asia","volume":"107","author":"Putsathit","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.cmi.2016.03.010","article-title":"European Society of Clinical Microbiology and Infectious Diseases: Update of the diagnostic guidance document for Clostridium difficile infection","volume":"22","author":"Crobach","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"Reigadas","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by IDSA and SHEA: 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","unstructured":"World Health Organization (2016). Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level, WHO."},{"key":"ref_32","unstructured":"World Health Organization Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022."},{"key":"ref_33","unstructured":"World Health Organization Regional Office for Europe Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR). Copenhagen: WHO Regional Office for Europe. Available online: https:\/\/www.who.int\/europe\/groups\/central-asian-and-european-surveillance-of-antimicrobial-resistance-(caesar)."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Scarlata, G.G.M., Quirino, A., Costache, C., Toc, D.A., Marascio, N., Pantanella, M., Leucuta, D.C., Ismaiel, A., Dumitrascu, D.L., and Abenavoli, L. (2024). Clostridioides difficile infection: Use of inflammatory biomarkers and hemogram-derived ratios to predict mortality risk in hospitalized patients. Antibiotics, 13.","DOI":"10.3390\/antibiotics13080769"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lohaj, O., Ko\u010dan, P., Bicekov\u00e1, A., and Javorsk\u00e1, D. (2026). Machine learning prediction of Clostridioides difficile infection in hospitalized COVID-19 patients across pandemic waves. Healthcare, 14.","DOI":"10.3390\/healthcare14131869"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/8\/853\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:49:28Z","timestamp":1786704568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/8\/853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pathogens15080853"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15080853","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}